Retinopathy of Prematurity Studies
Retinopathy of Prematurity Studies is a research topic within Radiology, Nuclear Medicine and Imaging. Science Explorer counts 13k research works in it since 1950. 15.1% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, treatment, and risk factors associated with retinopathy of prematurity, a potentially blinding eye disorder that primarily affects premature infants. It covers topics such as screening examinations, use of intravitreal bevacizumab, neurodevelopmental outcomes, and the role of vascular endothelial growth factor and oxygen in the pathogenesis of the condition.
- Retinopathy
- Prematurity
- Treatment
- Screening
- Infants
- Vascular Endothelial Growth Factor
- Oxygen
- Telemedicine
- Intravitreal Bevacizumab
- Neurodevelopmental Outcomes
- Research works
- 13k fractional, since 1950
- In the world top 10%
- 1.9k per year above
- Top-10% rate
- 15.1% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +26% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Retinopathy of Prematurity Studies research?
By volume, the United States and China publish the most (474 and 422 works in 2022–2025).
By volume, 2022–2025
- 1 United States 474 works
- 2 China 422 works
- 3 India 234 works
- 4 United Kingdom 111 works
- 5 Türkiye 84 works
- 6 Japan 70 works
- 7 Germany 63 works
- 8 Australia 57 works
- 9 Italy 49 works
- 10 Russia 48 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Retinopathy of Prematurity Studies research?
By volume in 2022–2025, Sun Yat-sen University publishes the most Retinopathy of Prematurity Studies research, followed by All India Institute of Medical Sciences and L V Prasad Eye Institute.
By volume, 2022–2025
- 1 Sun Yat-sen UniversityChina 22 works
- 2 All India Institute of Medical SciencesIndia 17 works
- 3 L V Prasad Eye InstituteIndia 16 works
- 4 Aravind Eye HospitalIndia 13 works
- 5 Sağlık Bilimleri ÜniversitesiTürkiye 13 works
- 6 Harvard UniversityUnited States 12 works
- 7 University College LondonUnited Kingdom 9 works
- 8 Wenzhou Medical UniversityChina 9 works
- 9 University of MiamiUnited States 8 works
- 10 He Eye HospitalChina 8 works
Who are the leading researchers in Retinopathy of Prematurity Studies?
The most-cited researchers publishing on Retinopathy of Prematurity Studies include Jost B. Jonas and Tien Yin Wong.
- 1 Jost B. Jonas Germany 7.7k citations
- 2 Tien Yin Wong Singapore 4.3k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Retinopathy of Prematurity Studies research done?
The largest centres of Retinopathy of Prematurity Studies research in 2022–2025 are Beijing (China), Guangzhou (China), London (United Kingdom) and Shanghai (China).
Largest cities, 2022–2025
Where is the best place to study Retinopathy of Prematurity Studies?
Among universities, judged by research, Wenzhou Medical University, All India Institute of Medical Sciences and Sun Yat-sen University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Wenzhou Medical UniversityChina | 61.3 | 33.6% | 11.3× | 9 | +32.9% |
| 2 | All India Institute of Medical SciencesIndia | 60.2 | 12.6% | 12.4× | 17 | +132.5% |
| 3 | Sun Yat-sen UniversityChina | 56.3 | 25.5% | 6.0× | 22 | +12.0% |
| 4 | Sağlık Bilimleri ÜniversitesiTürkiye | 44.0 | 5.9% | 9.7× | 13 | — |
| 5 | University of MiamiUnited States | 39.0 | 19.2% | 7.6× | 8 | +33.8% |
| 6 | Harvard UniversityUnited States | 38.2 | 22.8% | 4.1× | 12 | -7.1% |
| 7 | University College LondonUnited Kingdom | 37.5 | 25.9% | 3.0× | 9 | +24.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Retinopathy of Prematurity Studies research growing?
Output in 2018–2022 was 26% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Retinopathy of Prematurity Studies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.